Azitra, Inc.
AMEX:AZTRBiotechnology
Healthcare
$1.53 +113.99%
+$0.82 today
- Market cap
- $92.72M
- Beta
- -1.04
- P/E (TTM)
- -1.2
- EPS (TTM)
- -$0.64
52W Low $0.05High $2.13
Volume 146.25M
Average 11.12M
AZTR EBITDA Margin
EBITDA as a percentage of revenue.
Azitra, Inc.AMEX: AZTR
EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026
EBITDA Margin not reported for Q2 FY2026
Context
- EBITDA Margin widened in 1 of the last 2 fiscal years.
- FY2024 was the lowest level in the 3 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2024
- -113307.5%
- Year-over-year change
- -111751.7pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | — | — |
| FY2024 | 2024-12-31 | -113307.5% | -111751.7pp |
| FY2023 | 2023-12-31 | -1555.9% | +1973.2pp |
| FY2022 | 2022-12-31 | -3529.0% | +4460.0pp |
| FY2021 | 2021-12-31 | -7989.0% | — |
Sign in to see up to ten periods of history.Sign in
EBITDA Margin vs competitors
How AZTR compares with its peers on the latest reported figures
No competitor EBITDA Margin figures are available to compare.
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 110K | 284K | 686K | 7.5K | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 110K | 284K | 686K | 7.5K | 0 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | — |
| Research & Development | 5.38M | 6.1M | 3.64M | 4.72M | 4.84M |
| Selling, General & Admin | 3.95M | 3.64M | 4.49M | 6.27M | 6.13M |
| Operating Expenses | 9.33M | 9.74M | 8.14M | 10.99M | 10.97M |
| Depreciation & Amortization | 84.77K | 405.98K | 425.55K | 448.24K | 453.14K |
| EBITDA | (8.79M) | (10.02M) | (10.67M) | (8.5M) | (10.49M) |
| EBITDA Margin | -7989.0% | -3529.0% | -1555.9% | -113307.5% | — |
| Operating Income | (9.22M) | (9.45M) | (7.45M) | (10.99M) | (10.97M) |
| Operating Margin | -8383.1% | -3328.7% | -1086.1% | -146468.5% | — |
| Interest Income | 8.76K | 4.82K | 1.58K | 122.55K | 70.21K |
| Interest Expense | 66.97K | 251.89K | 167.73K | 12.16K | 7.59K |
| Other Income / Expenses | 281.78K | (1.23M) | (3.82M) | 2.03M | 19.61K |
| Income Before Tax | (8.94M) | (10.68M) | (11.27M) | (8.96M) | (10.95M) |
| Pre-Tax Margin | -8127.0% | -3760.7% | -1642.3% | -119446.1% | — |
| Income Tax Expense | 0 | 0 | 17.31K | 9.03K | 8.32K |
| Net Income | (8.94M) | (10.68M) | (11.28M) | (8.97M) | (10.96M) |
| Net Margin | -8127.0% | -3760.7% | -1644.9% | -119566.6% | — |
| EPS (Basic) | (193.55) | (222.33) | (208.74) | (15.78) | (2.25) |
| EPS (Diluted) | (193.55) | (222.33) | (208.74) | (15.78) | (2.25) |
| Weighted Avg Shares | 60.49K | 60.49K | 60.55K | 568.24K | 4.87M |
| Weighted Avg Shares (Diluted) | 60.49K | 60.49K | 60.55K | 568.24K | 4.87M |
Azitra, Inc.
AMEX:AZTR
Intrinsic Alpha fair value
Locked
Current Price
$1.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.